2014 Impact Factor up to 5.629 - Clinical Science has received its highest ever Impact Factor of 5.629 in the 2013 Journal Citation Reports (Thomson Reuters 2014). A Top Quartile Journal in the Medicine (Research & Experimental) category, Clinical Science is now ranked 14 out of 122.

Latest Collection

50 Years of FEBS - In celebration of the 50th Anniversary of the Federation of European Biochemical Societies (FEBS), we have made freely available for 3 months 50 high-quality papers published in the Portland Press family of journals (Biochemical Journal, Biochemical Society Transactions, Bioscience Reports and Clinical Science) by authors in 22 of the FEBS member countries.

New Call For Papers

NADPH Oxidases in Health and Disease - we invite the submission of original papers by the deadline of 31 December 2014

Meeting Highlight

BSCR Autumn Meeting - Cardiovascular Signalling in Health and Disease, 8-9 September 2014, Reading, U.K. >> Meeting website


Amalia Forte, Barbara Rinaldi, Liberato Berrino, Francesco Rossi, Umberto Galderisi and Marilena Cipollaro (Department of Experimental Medicine, Second University of Naples, Naples, Italy)

Restenosis is the pathophysiological process occurring in 10-15% of patients submitted to revascularization procedures of coronary, carotid and peripheral arteries. The use of pre-clinical models of (re)stenosis has contributed enormously to the identification of processes involved in restenosis progression and has served as a basis for identifying novel potential therapeutic targets. In the present review, the authors summarize the most recent and promising therapeutic strategies identified in experimental models of (re)stenosis and potentially translatable to patients subjected to revascularization procedures.